Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Risk Factors for Pericardial Effusion in Patients with Stage I Esophageal Cancer Treated with Chemoradiotherapy

KEISUKE TAMARI, FUMIAKI ISOHASHI, YUICHI AKINO, OSAMU SUZUKI, YUJI SEO, YASUO YOSHIOKA, YOSHITO HAYASHI, TSUTOMU NISHIDA, TETSUO TAKEHARA, MASAKI MORI, YUICHIRO DOKI and KAZUHIKO OGAWA
Anticancer Research December 2014, 34 (12) 7389-7393;
KEISUKE TAMARI
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tamari{at}radonc.med.osaka-u.ac.jp
FUMIAKI ISOHASHI
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHI AKINO
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OSAMU SUZUKI
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJI SEO
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUO YOSHIOKA
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHITO HAYASHI
2Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUTOMU NISHIDA
2Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSUO TAKEHARA
2Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKI MORI
3Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHIRO DOKI
3Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIKO OGAWA
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Cumulative incidence rate of PCE.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Cumulative incidence rate of PCE with respect to pericardial V30. Patients were divided into two groups based on pericardial V30: <41.6% and ≥41.6%.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Cumulative incidence rate of PCE with respect to number (n) of risk factors. The risk factors are pericardial V30 ≥41.6%, BMI ≥19, age ≥66 years and diabetes mellitus.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 34, Issue 12
December 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk Factors for Pericardial Effusion in Patients with Stage I Esophageal Cancer Treated with Chemoradiotherapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Risk Factors for Pericardial Effusion in Patients with Stage I Esophageal Cancer Treated with Chemoradiotherapy
KEISUKE TAMARI, FUMIAKI ISOHASHI, YUICHI AKINO, OSAMU SUZUKI, YUJI SEO, YASUO YOSHIOKA, YOSHITO HAYASHI, TSUTOMU NISHIDA, TETSUO TAKEHARA, MASAKI MORI, YUICHIRO DOKI, KAZUHIKO OGAWA
Anticancer Research Dec 2014, 34 (12) 7389-7393;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Risk Factors for Pericardial Effusion in Patients with Stage I Esophageal Cancer Treated with Chemoradiotherapy
KEISUKE TAMARI, FUMIAKI ISOHASHI, YUICHI AKINO, OSAMU SUZUKI, YUJI SEO, YASUO YOSHIOKA, YOSHITO HAYASHI, TSUTOMU NISHIDA, TETSUO TAKEHARA, MASAKI MORI, YUICHIRO DOKI, KAZUHIKO OGAWA
Anticancer Research Dec 2014, 34 (12) 7389-7393;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis
  • Google Scholar

More in this TOC Section

  • Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance
  • Prognostic Difference According to the Site of Origin (Major vs. Minor) of Salivary Gland Carcinoma
  • Prognostic Significance of the Lymph Node Ratio in Obstructive Colorectal Cancer: A Retrospective Multicenter Study
Show more Clinical Studies

Keywords

  • pericardial effusion
  • Esophageal cancer
  • dose-volume histogram
  • chemoradiotherapy
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire